Hypokalemia in acute myelogenous leukemia.
Forty-two patients with acute myelogenous leukemia or one of its variants were studied at diagnosis to determine the incidence and cause(s) of hypokalemia. Forty-three percent of patients were hypokalemic, and an inappropriate renal loss of potassium was noted. This potassium wastage could not be explained by antibiotic-induced renal tubular dysfunction, lysozymuria, or alterations in renin-aldosterone secretion.
D000450:Aldosterone / Q000097:blood; D000900:Anti-Bacterial Agents / Q000009:adverse effects; D005260:Female; D006801:Humans; D007008:Hypokalemia / Q000209:etiology* / Q000652:urine; D007684:Kidney Tubules / Q000503:physiopathology; D015470:Leukemia, Myeloid, Acute / Q000150:complications* / Q000652:urine; D008297:Male; D008875:Middle Aged; D009113:Muramidase / Q000097:blood / Q000652:urine; D011188:Potassium / Q000652:urine; D012083:Renin / Q000097:blood; D012964:Sodium / Q000652:urine
D000900:Anti-Bacterial Agents; D000450:Aldosterone; D012964:Sodium; D009113:Muramidase; D012083:Renin; D011188:Potassium